Charged Multivesicular Body Protein 4A (CHMP4A) (C-Term) Peptide
CHMP4A
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all CHMP4A products
- CHMP4A (Charged Multivesicular Body Protein 4A (CHMP4A))
- 蛋白结构域
- C-Term
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- ELEQEELAQE LLNVGDKEEE PSVKLPSVPS THLPAGPAPK VDEDEEALKQ
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-CHMP4A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- CHMP4A (Charged Multivesicular Body Protein 4A (CHMP4A))
- 背景
-
CHMP4A belongs to the chromatin-modifying protein/charged multivesicular body protein (CHMP) family. These proteins are components of ESCRT-III (endosomal sorting complex required for transport III), a complex involved in degradation of surface receptor proteins and formation of endocytic multivesicular bodies (MVBs). Some CHMPs have both nuclear and cytoplasmic/vesicular distributions, and one such CHMP, CHMP1A, is required for both MVB formation and regulation of cell cycle progression
Alias Symbols: C14orf123, CHMP4, CHMP4B, FLJ61658, HSPC134, MGC142093, MGC142095, SNF7, SNF7-1, Shax2, VPS32A, SHAX2, VPS32-1
Protein Interaction Partner: PDCD6IP,PDCD6IP,VPS4A,CC2D1A,CDK13,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,PDCD6IP,SYT17,TTC19,VPS4A,STAMBP,SYT17
Protein Size: 265 - 分子量
- 29 kDa
- 基因ID
- 29082
- NCBI登录号
- NM_014169, NP_054888
- UniProt
- Q14D22
-
You are here:
